Increased risks of developing anxiety and depression in young patients with crohn's disease

American Journal of Gastroenterology

Volumn 106, Issue 9, 2011, Pages 1670-1677

  Loftus Jr , Edward V ^a   Guérin, Annie ^b   Yu, Andrew P ^c   Wu, Eric Q ^c   Yang, Mei ^d   Chao, Jingdong ^d   Mulani, Parvez M ^d  

^a MAYO CLINIC   (United States)

^b STATISTICS CANADA   (Canada)

^c ANALYSIS GROUP   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY; ANXIETY DISORDERS; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INCIDENCE; INFANT; INSURANCE, HEALTH; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 80052445572     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.142     Document Type: Article

References (45)

1. Loft us EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002; 16: 51-60. (Pubitemid 34123864)
2. Herrinton LJ, Liu L, Lewis JD et al. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization 1996-2002. Am J Gastroenterol 2008; 103: 1998-2006.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Gastroenterol Hepatol 2007; 5: 1424-9. (Pubitemid 350181588)
4. Loft us CG, Loft us EV Jr, Harmsen WS et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota 1940-2000. Inflamm Bowel Dis 2007; 13: 254-61. (Pubitemid 46465905)
5. Loft us EV Jr, Silverstein MD, Sandborn WJ et al. Crohn's disease in Olmsted County, Minnesota 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-8.
6. Karwowski CA, Keljo D, Szigethy E. Strategies to improve quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1755-64.
7. King RA. Pediatric inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 2003; 12: 537-50. (Pubitemid 36886017)
8. Fuller-Thomson E, Sulman J. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006; 12: 697-707. (Pubitemid 44253753)
9. Kurina LM, Goldacre MJ, Yeates D et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health 2001; 55: 716-20. (Pubitemid 32881818)
10. Maunder RG, Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr Mol Med 2008; 8: 247-52. (Pubitemid 351982528)
11. Addolorato G, Mirijello A, D ' Angelo C et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting . Int J Clin Pract 2008; 62: 1063-9. (Pubitemid 351793590)
12. Iglesias M, Barreiro de Acosta M, V á zquez I et al. Psychological impact of Crohn's disease on patients in remission: anxiety and depression risks. Rev Esp Enferm Dig 2009; 101: 249-57.
13. Strine TW, Mokdad AH, Balluz LS et al. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv 2008; 59: 1383-90.
14. Petrak F, Hardt J, Clement T et al. Impaired health-related quality of life in inflammatory bowel diseases: psychosocial impact and coping styles in a national German sample. Scand J Gastroenterol 2001; 36: 375-82. (Pubitemid 32250733)
15. Juan J, Estiarte R, Colom é E et al. Burden of illness of Crohn's disease in Spain. Dig Liver Dis 2003; 35: 853-61. (Pubitemid 41070490)
16. Brandi MT, Ribeiro MS, Chebli LA et al. Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors. Med Sci Monit 2009; 15: PH101-8.
17. Graff LA, Walker JR, Lix L et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006; 4: 1491-501.
18. Lix LM, Graff LA, Walker JR et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008; 14: 1575-84.
19. Walker JR, Ediger JP, Graff LA et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol 2008; 103: 1989-97.
20. Bernstein CN, Singh S, Graff LA et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010; 105: 1994-2002.
21. Peterson KD. Inflammatory bowel disease: impact on early teenage years. Gastroenterol Nurs 2008; 31: 235-6.
22. Marcus SB, Strople JA, Neighbors K et al. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol 2009; 7: 554-61.
23. Mason A, Wong SC, McGrogan P et al. effect of testosterone therapy for delayed growth and puberty in boys with inflammatory bowel disease. Horm Res Paediatr 2011; 75: 8-13.
24. Greenley RN, Hommel KA, Nebel J et al. A meta-analytic review of the psychosocial adjustment of youth with inflammatory bowel disease. J Pediatr Psychol 2010; 35: 857-69.
25. Szigethy E, Levy-Warren A, Whitton S et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr 2004; 39: 395-403.
26. Kim-Cohen J, Caspi A, Moffitt TE et al. Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective- longitudinal cohort. Arch Gen Psychiatry 2003; 60: 709-17. (Pubitemid 36818633)
27. Copeland WE, Shanahan L, Costello J et al. Childhood and adolescent psychiatric disorders as predictors of young adult disorders. Arch Gen Psychiatry 2009; 66: 764-72.
28. Zima BT, Bussing R, Crecelius GM et al. Psychotropic medication use among children in foster care: relationship to severe psychiatric disorders. Am J Public Health 1999; 89: 1732-5. (Pubitemid 29508223)
29. McCranie EW, Riley WT. Hopelessness and persistence of depression in an inpatient sample. Cognit Ther Res 1992; 16: 699-708.
30. Lane D, Carroll D, Ring C et al. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol 2002; 7: 11-21. (Pubitemid 34174896)
31. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-9.
32. Addolorato G, Capristo E, Stefanini nini GF et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997; 32: 1013-21. (Pubitemid 27433665)
33. Engstrom I. Inflammatory bowel disease in children and adolescents: mental health and family function. J Pediatr Gastroenterol Nutr 1999; 28: S28-33. (Pubitemid 30349264)
34. Greydanus D, Patel D, Pratt H. Suicide risk in adolescents with chronic illness: implications for primary care and specialty pediatric practice: a review. Dev Med Child Neurol 2010; 52: 1083-7.
35. de Carpi JM. Psychosocial features of inflammatory bowel disease in the pediatric age group: acceptance of and adaptation to the disease. Gastroenterol Hepatol 2009; 32 (Suppl 2): 25.
36. Engstrom I. Mental health and psychological functioning in children and adolescents with inflammatory bowel disease: a comparison with children having other chronic illnesses and with healthy children. J Child Psychol Psychiatry 1992; 33: 563-92.
37. Goodwin RD, Fergusson DM, Horwood LJ. Asthma and depressive and anxiety disorders among young persons in the community. Psychol Med 2004; 34: 1465-74. (Pubitemid 39599944)
38. Peters TE, Fritz GK. Psychological considerations of the child with asthma. Child Adolesc Psychiatr Clin N Am 2010; 19: 319-33.
39. Kurtz BP, Abrams AN. Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatr Clin N Am 2010; 19: 401-21.
40. Brown ES. effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 2009; 1179: 41-55.
41. Pine DS, Cohen P, Gurley D et al. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry 1998; 55: 56-64. (Pubitemid 28069040)
42. Pine DS, Cohen E, Cohen P et al. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? Am J Psychiatry 1999; 156: 133-5. (Pubitemid 29034892)
43. Mikocka-Walus AA, Turnbull DA, Moulding NT et al. Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review. Inflamm Bowel Dis 2007; 13: 225-34. (Pubitemid 46806232)
44. Szigethy E, Craig AE, Iobst EA et al. Profile of depression in adolescents with inflammatory bowel disease: implications for treatment. Inflamm Bowel Dis 2009; 15: 69-74.
45. Mojtabai R. Diagnosing depression and prescribing antidepressants by primary care physicians: the impact of practice style variations. Ment Health Serv Res 2002; 4: 109-18 (Pubitemid 34746134)